In a reversal, the FDA is reconsidering its decision to end the shortage status of tirzepatide, after a recent lawsuit and intense public pressure, The Washington Post reported Oct. 21.
Ozempic, Mounjaro and similar medications for Type 2 diabetes and weight loss could also help people struggling with addiction, according to a new study. Researchers found that people addicted to ...
The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.